A Pilot study of anti-diabetic effects of rich Oligosaccharides fraction which is taken from Rosa arvensis in patients with type 2 diabetes
Not Applicable
- Conditions
- diabetes of type2.Non-insulin dependent diabetes mellitus
- Registration Number
- IRCT2013120214333N13
- Lead Sponsor
- Barekat Pharmaceutical Company
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
diabetes diagnosis with fasting blood sugar over 125, or postprandial glucose over 200 or glycosylated hemoglobin level greater than 6; patient willingness and signed informed consent, age less than 65 years; history of diabetes less than 10 years; diabetes onset at least three months before.
Exclusion criteria: requiring insulin injections or diagnosis of type 1 diabetes, kidney disease, liver disease, cancer, anemia and heart failure, pregnancy, glycosylated hemoglobin over 10, corticosteroids use.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood sugar (FBS). Timepoint: Baseline, 3 and 6 months after starting the study. Method of measurement: Test.;Glucose tolerance test (BS). Timepoint: Baseline, 3 and 6 months after starting the study. Method of measurement: Test.;Hba1c rate. Timepoint: Baseline, 3 and 6 months after starting the study. Method of measurement: Test.
- Secondary Outcome Measures
Name Time Method